-
The Future of Biomarker-Guided Therapy for Heart Failure After the Guiding Evidence-Based Therapy Using Biomarker Intensified Treatment in Heart Failure (GUIDE-IT) StudyIbrahim NE, Januzzi JL Jr. -
Phenomapping for Novel Classification of Heart Failure With Preserved Ejection FractionShah SJ, Katz DH, Selvaraj S et al.
-
2019 ACC Expert Consensus Decision Pathway on Risk Assessment, Management, and Clinical Trajectory of Patients Hospitalized With Heart Failure: A Report of the American College of Cardiology Solution Set Oversight CommitteeHollenberg SM, Warner Stevenson L, Ahmad T
-
The spectrum of heart failure: value of left ventricular ejection fraction and its moving trajectoriesTF Lüscher
-
Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trialMorrow DA, Velazquez EJ, DeVore AD et al.
-
Circulating sST2 and catestatin levels in patients with acute worsening of heart failure: a report from the CATSTAT-HF studyJA Borovac, D Glavas, ZS Grabovac et al.
-
Frequency, predictors, and prognosis of ejection fraction improvement in heart failure: an echocardiogram-based registry studyA Ghimire, N Fine, FA McAlister et al.
-
Association of Prior Left Ventricular Ejection Fraction With Clinical Outcomes in Patients With Heart Failure With Midrange Ejection FractionA Brann, S Janvanishstaporn, B Greenberg et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
